TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO. Stock

Certificat

DE000SD4MA43

Real-time Boerse Frankfurt Warrants 06:04:27 2024-06-03 EDT
4.29 EUR -0.69% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - MERCK & CO.
1 month-9.81%
3 months-7.10%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-03 4.29 -0.69%
24-05-31 4.32 +0.93%
24-05-30 4.28 -2.51%
24-05-29 4.39 +0.46%
24-05-28 4.37 -5.00%

Real-time Boerse Frankfurt Warrants

Last update June 03, 2024 at 06:04 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SD4MA4
ISINDE000SD4MA43
Date issued 2021-03-12
Strike 79.01 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.45
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.1
Lowest since issue 0.23
Spread 0.06
Spread %1.38%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus